EAACI Congress 2024

Back
31 May - 03 June 2024 Valencia, Spain

Advances in Allergen Immunotherapy

Friday 31 May, 08:30 AM - 10:00 AM Valencia, Spain
Bilbao Oral Abstract Sessions
08:30
5-year patient-reported outcomes after oral immunotherapy using heat-modified peanuts: results from the BOPI (Boiled Peanut Oral Immunotherapy) study
08:42
Immunotherapy with Vespa velutina nigrithorax venom: safety of ultra-rush protocol and preliminary clinical results
08:54
Safety of a cluster strategy, effectiveness and immunological changes in allergic children sensitized to house dust mites with native and modified subcutaneous immunotherapy treatment
09:06
Effect of allergen specific immunotherapy on PFS symptoms
09:18
Patient preference: A multinational discrete-choice-experiment (DCE) in pollen allergen immunotherapy (AIT)
09:30
Predicting the Efficacy of Allergen Immunotherapy in Asthma Based on Initial-Year Outcome: Insights from the Estimated Daily Symptom and Medication Score
09:42
Assessment of safety and treatment of a subcutaneous cluster immunotherapy with a high-polymerized pollen extract (allergoid) of birch in a DBPC phase II study

Speakers